Email
Print
1. Human Vaccines Market - Overview
1.1 Definitions and Scope
2. Human Vaccines Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Human Vaccines Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Human Vaccines Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Human Vaccines Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Human Vaccines Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Human Vaccines Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Human Vaccines Market - By Product Type(Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
8.3.1 Pneumococcal
8.3.2 Influenza
8.3.3 Hepatitis
8.3.4 HPV
8.3.5 Meningococcal
8.3.6 Rotavirus
8.3.7 Measles and Rubella
8.3.8 Typhoid
8.3.9 Combination
9. Human Vaccines Market - By Type(Market Size -$Million / $Billion)
9.1 Human Vaccines Market Analysis, by Vaccine Type
9.1.1 Conjugate
9.1.2 Recombinant
9.1.3 Conjugate Vaccines
9.1.4 Inactivated
9.1.5 Combination
9.1.6 Attenuated
9.2 Human Vaccines Market Analysis, by Distribution Channel
9.2.1 Hospital Pharmacies
9.2.2 Drugstores
9.3 Human Vaccines Market Analysis, by Age Group
9.3.1 Pediatrics
9.3.2 Adolescents
9.3.3 Adults
9.3.4 Geriatrics
10. Human Vaccines - By Application Type(Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. Human Vaccines- By Geography (Market Size -$Million / $Billion)
11.1 Human Vaccines Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Human Vaccines- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Human Vaccines- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Human Vaccines - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Human Vaccines - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Human Vaccines Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Human Vaccines Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Human Vaccines Market - Key Company List by Country Premium
15. Human Vaccines Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 AstraZeneca
15.3 Bavarian
15.4 Bharat Biotech
15.5 CSL Limited
15.6 Emergent BioSolutions, Inc.
15.7 GlaxoSmithKline plc
15.8 Johnson Johnson
15.9 Merck Co., Inc.
15.10 Mymetics
15.11 Novartis AG
15.12 Pfizer, Inc.
15.13 Sanofi
15.14 Shenzhen Kangtai Biological Products Co., Ltd.
15.15 Takeda Pharmaceutical Company Limited.
15.16 Company 16
15.17 Company 17 & More
16.1 Abbreviations
16.2 Sources
17. Human Vaccines Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Human Vaccines Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Human Vaccines Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Human Vaccines Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Human Vaccines Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Human Vaccines Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Human Vaccines Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Human Vaccines Market - By Product Type(Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
8.3.1 Pneumococcal
8.3.2 Influenza
8.3.3 Hepatitis
8.3.4 HPV
8.3.5 Meningococcal
8.3.6 Rotavirus
8.3.7 Measles and Rubella
8.3.8 Typhoid
8.3.9 Combination
9. Human Vaccines Market - By Type(Market Size -$Million / $Billion)
9.1 Human Vaccines Market Analysis, by Vaccine Type
9.1.1 Conjugate
9.1.2 Recombinant
9.1.3 Conjugate Vaccines
9.1.4 Inactivated
9.1.5 Combination
9.1.6 Attenuated
9.2 Human Vaccines Market Analysis, by Distribution Channel
9.2.1 Hospital Pharmacies
9.2.2 Drugstores
9.3 Human Vaccines Market Analysis, by Age Group
9.3.1 Pediatrics
9.3.2 Adolescents
9.3.3 Adults
9.3.4 Geriatrics
10. Human Vaccines - By Application Type(Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. Human Vaccines- By Geography (Market Size -$Million / $Billion)
11.1 Human Vaccines Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Human Vaccines- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Human Vaccines- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Human Vaccines - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Human Vaccines - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Human Vaccines Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Human Vaccines Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Human Vaccines Market - Key Company List by Country Premium
15. Human Vaccines Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 AstraZeneca
15.3 Bavarian
15.4 Bharat Biotech
15.5 CSL Limited
15.6 Emergent BioSolutions, Inc.
15.7 GlaxoSmithKline plc
15.8 Johnson Johnson
15.9 Merck Co., Inc.
15.10 Mymetics
15.11 Novartis AG
15.12 Pfizer, Inc.
15.13 Sanofi
15.14 Shenzhen Kangtai Biological Products Co., Ltd.
15.15 Takeda Pharmaceutical Company Limited.
15.16 Company 16
15.17 Company 17 & More
*Financials would be provided on a best efforts basis for private companies
16. Human Vaccines Market - Appendix16.1 Abbreviations
16.2 Sources
17. Human Vaccines Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Human Vaccines Market Analysis, by Vaccine Type Market 2023-2030 ($M)1.1 Conjugate Market 2023-2030 ($M) - Global Industry Research
1.2 Recombinant Market 2023-2030 ($M) - Global Industry Research
1.3 Conjugate Vaccines Market 2023-2030 ($M) - Global Industry Research
1.4 Inactivated Market 2023-2030 ($M) - Global Industry Research
1.5 Combination Market 2023-2030 ($M) - Global Industry Research
1.6 Attenuated Market 2023-2030 ($M) - Global Industry Research
2.Global Human Vaccines Market Analysis, by Product Market 2023-2030 ($M)
2.1 Pneumococcal Market 2023-2030 ($M) - Global Industry Research
2.2 Influenza Market 2023-2030 ($M) - Global Industry Research
2.3 Hepatitis Market 2023-2030 ($M) - Global Industry Research
2.4 HPV Market 2023-2030 ($M) - Global Industry Research
2.5 Meningococcal Market 2023-2030 ($M) - Global Industry Research
2.6 Rotavirus Market 2023-2030 ($M) - Global Industry Research
2.7 Measles and Rubella Market 2023-2030 ($M) - Global Industry Research
2.8 Typhoid Market 2023-2030 ($M) - Global Industry Research
2.9 Combination Market 2023-2030 ($M) - Global Industry Research
3.Global Human Vaccines Market Analysis, by Distribution Channel Market 2023-2030 ($M)
3.1 Hospital Pharmacies Market 2023-2030 ($M) - Global Industry Research
3.2 Drugstores Market 2023-2030 ($M) - Global Industry Research
4.Global Human Vaccines Market Analysis, by Age Group Market 2023-2030 ($M)
4.1 Pediatrics Market 2023-2030 ($M) - Global Industry Research
4.2 Adolescents Market 2023-2030 ($M) - Global Industry Research
4.3 Adults Market 2023-2030 ($M) - Global Industry Research
4.4 Geriatrics Market 2023-2030 ($M) - Global Industry Research
5.Global Human Vaccines Market Analysis, by Vaccine Type Market 2023-2030 (Volume/Units)
5.1 Conjugate Market 2023-2030 (Volume/Units) - Global Industry Research
5.2 Recombinant Market 2023-2030 (Volume/Units) - Global Industry Research
5.3 Conjugate Vaccines Market 2023-2030 (Volume/Units) - Global Industry Research
5.4 Inactivated Market 2023-2030 (Volume/Units) - Global Industry Research
5.5 Combination Market 2023-2030 (Volume/Units) - Global Industry Research
5.6 Attenuated Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global Human Vaccines Market Analysis, by Product Market 2023-2030 (Volume/Units)
6.1 Pneumococcal Market 2023-2030 (Volume/Units) - Global Industry Research
6.2 Influenza Market 2023-2030 (Volume/Units) - Global Industry Research
6.3 Hepatitis Market 2023-2030 (Volume/Units) - Global Industry Research
6.4 HPV Market 2023-2030 (Volume/Units) - Global Industry Research
6.5 Meningococcal Market 2023-2030 (Volume/Units) - Global Industry Research
6.6 Rotavirus Market 2023-2030 (Volume/Units) - Global Industry Research
6.7 Measles and Rubella Market 2023-2030 (Volume/Units) - Global Industry Research
6.8 Typhoid Market 2023-2030 (Volume/Units) - Global Industry Research
6.9 Combination Market 2023-2030 (Volume/Units) - Global Industry Research
7.Global Human Vaccines Market Analysis, by Distribution Channel Market 2023-2030 (Volume/Units)
7.1 Hospital Pharmacies Market 2023-2030 (Volume/Units) - Global Industry Research
7.2 Drugstores Market 2023-2030 (Volume/Units) - Global Industry Research
8.Global Human Vaccines Market Analysis, by Age Group Market 2023-2030 (Volume/Units)
8.1 Pediatrics Market 2023-2030 (Volume/Units) - Global Industry Research
8.2 Adolescents Market 2023-2030 (Volume/Units) - Global Industry Research
8.3 Adults Market 2023-2030 (Volume/Units) - Global Industry Research
8.4 Geriatrics Market 2023-2030 (Volume/Units) - Global Industry Research
9.North America Human Vaccines Market Analysis, by Vaccine Type Market 2023-2030 ($M)
9.1 Conjugate Market 2023-2030 ($M) - Regional Industry Research
9.2 Recombinant Market 2023-2030 ($M) - Regional Industry Research
9.3 Conjugate Vaccines Market 2023-2030 ($M) - Regional Industry Research
9.4 Inactivated Market 2023-2030 ($M) - Regional Industry Research
9.5 Combination Market 2023-2030 ($M) - Regional Industry Research
9.6 Attenuated Market 2023-2030 ($M) - Regional Industry Research
10.North America Human Vaccines Market Analysis, by Product Market 2023-2030 ($M)
10.1 Pneumococcal Market 2023-2030 ($M) - Regional Industry Research
10.2 Influenza Market 2023-2030 ($M) - Regional Industry Research
10.3 Hepatitis Market 2023-2030 ($M) - Regional Industry Research
10.4 HPV Market 2023-2030 ($M) - Regional Industry Research
10.5 Meningococcal Market 2023-2030 ($M) - Regional Industry Research
10.6 Rotavirus Market 2023-2030 ($M) - Regional Industry Research
10.7 Measles and Rubella Market 2023-2030 ($M) - Regional Industry Research
10.8 Typhoid Market 2023-2030 ($M) - Regional Industry Research
10.9 Combination Market 2023-2030 ($M) - Regional Industry Research
11.North America Human Vaccines Market Analysis, by Distribution Channel Market 2023-2030 ($M)
11.1 Hospital Pharmacies Market 2023-2030 ($M) - Regional Industry Research
11.2 Drugstores Market 2023-2030 ($M) - Regional Industry Research
12.North America Human Vaccines Market Analysis, by Age Group Market 2023-2030 ($M)
12.1 Pediatrics Market 2023-2030 ($M) - Regional Industry Research
12.2 Adolescents Market 2023-2030 ($M) - Regional Industry Research
12.3 Adults Market 2023-2030 ($M) - Regional Industry Research
12.4 Geriatrics Market 2023-2030 ($M) - Regional Industry Research
13.South America Human Vaccines Market Analysis, by Vaccine Type Market 2023-2030 ($M)
13.1 Conjugate Market 2023-2030 ($M) - Regional Industry Research
13.2 Recombinant Market 2023-2030 ($M) - Regional Industry Research
13.3 Conjugate Vaccines Market 2023-2030 ($M) - Regional Industry Research
13.4 Inactivated Market 2023-2030 ($M) - Regional Industry Research
13.5 Combination Market 2023-2030 ($M) - Regional Industry Research
13.6 Attenuated Market 2023-2030 ($M) - Regional Industry Research
14.South America Human Vaccines Market Analysis, by Product Market 2023-2030 ($M)
14.1 Pneumococcal Market 2023-2030 ($M) - Regional Industry Research
14.2 Influenza Market 2023-2030 ($M) - Regional Industry Research
14.3 Hepatitis Market 2023-2030 ($M) - Regional Industry Research
14.4 HPV Market 2023-2030 ($M) - Regional Industry Research
14.5 Meningococcal Market 2023-2030 ($M) - Regional Industry Research
14.6 Rotavirus Market 2023-2030 ($M) - Regional Industry Research
14.7 Measles and Rubella Market 2023-2030 ($M) - Regional Industry Research
14.8 Typhoid Market 2023-2030 ($M) - Regional Industry Research
14.9 Combination Market 2023-2030 ($M) - Regional Industry Research
15.South America Human Vaccines Market Analysis, by Distribution Channel Market 2023-2030 ($M)
15.1 Hospital Pharmacies Market 2023-2030 ($M) - Regional Industry Research
15.2 Drugstores Market 2023-2030 ($M) - Regional Industry Research
16.South America Human Vaccines Market Analysis, by Age Group Market 2023-2030 ($M)
16.1 Pediatrics Market 2023-2030 ($M) - Regional Industry Research
16.2 Adolescents Market 2023-2030 ($M) - Regional Industry Research
16.3 Adults Market 2023-2030 ($M) - Regional Industry Research
16.4 Geriatrics Market 2023-2030 ($M) - Regional Industry Research
17.Europe Human Vaccines Market Analysis, by Vaccine Type Market 2023-2030 ($M)
17.1 Conjugate Market 2023-2030 ($M) - Regional Industry Research
17.2 Recombinant Market 2023-2030 ($M) - Regional Industry Research
17.3 Conjugate Vaccines Market 2023-2030 ($M) - Regional Industry Research
17.4 Inactivated Market 2023-2030 ($M) - Regional Industry Research
17.5 Combination Market 2023-2030 ($M) - Regional Industry Research
17.6 Attenuated Market 2023-2030 ($M) - Regional Industry Research
18.Europe Human Vaccines Market Analysis, by Product Market 2023-2030 ($M)
18.1 Pneumococcal Market 2023-2030 ($M) - Regional Industry Research
18.2 Influenza Market 2023-2030 ($M) - Regional Industry Research
18.3 Hepatitis Market 2023-2030 ($M) - Regional Industry Research
18.4 HPV Market 2023-2030 ($M) - Regional Industry Research
18.5 Meningococcal Market 2023-2030 ($M) - Regional Industry Research
18.6 Rotavirus Market 2023-2030 ($M) - Regional Industry Research
18.7 Measles and Rubella Market 2023-2030 ($M) - Regional Industry Research
18.8 Typhoid Market 2023-2030 ($M) - Regional Industry Research
18.9 Combination Market 2023-2030 ($M) - Regional Industry Research
19.Europe Human Vaccines Market Analysis, by Distribution Channel Market 2023-2030 ($M)
19.1 Hospital Pharmacies Market 2023-2030 ($M) - Regional Industry Research
19.2 Drugstores Market 2023-2030 ($M) - Regional Industry Research
20.Europe Human Vaccines Market Analysis, by Age Group Market 2023-2030 ($M)
20.1 Pediatrics Market 2023-2030 ($M) - Regional Industry Research
20.2 Adolescents Market 2023-2030 ($M) - Regional Industry Research
20.3 Adults Market 2023-2030 ($M) - Regional Industry Research
20.4 Geriatrics Market 2023-2030 ($M) - Regional Industry Research
21.APAC Human Vaccines Market Analysis, by Vaccine Type Market 2023-2030 ($M)
21.1 Conjugate Market 2023-2030 ($M) - Regional Industry Research
21.2 Recombinant Market 2023-2030 ($M) - Regional Industry Research
21.3 Conjugate Vaccines Market 2023-2030 ($M) - Regional Industry Research
21.4 Inactivated Market 2023-2030 ($M) - Regional Industry Research
21.5 Combination Market 2023-2030 ($M) - Regional Industry Research
21.6 Attenuated Market 2023-2030 ($M) - Regional Industry Research
22.APAC Human Vaccines Market Analysis, by Product Market 2023-2030 ($M)
22.1 Pneumococcal Market 2023-2030 ($M) - Regional Industry Research
22.2 Influenza Market 2023-2030 ($M) - Regional Industry Research
22.3 Hepatitis Market 2023-2030 ($M) - Regional Industry Research
22.4 HPV Market 2023-2030 ($M) - Regional Industry Research
22.5 Meningococcal Market 2023-2030 ($M) - Regional Industry Research
22.6 Rotavirus Market 2023-2030 ($M) - Regional Industry Research
22.7 Measles and Rubella Market 2023-2030 ($M) - Regional Industry Research
22.8 Typhoid Market 2023-2030 ($M) - Regional Industry Research
22.9 Combination Market 2023-2030 ($M) - Regional Industry Research
23.APAC Human Vaccines Market Analysis, by Distribution Channel Market 2023-2030 ($M)
23.1 Hospital Pharmacies Market 2023-2030 ($M) - Regional Industry Research
23.2 Drugstores Market 2023-2030 ($M) - Regional Industry Research
24.APAC Human Vaccines Market Analysis, by Age Group Market 2023-2030 ($M)
24.1 Pediatrics Market 2023-2030 ($M) - Regional Industry Research
24.2 Adolescents Market 2023-2030 ($M) - Regional Industry Research
24.3 Adults Market 2023-2030 ($M) - Regional Industry Research
24.4 Geriatrics Market 2023-2030 ($M) - Regional Industry Research
25.MENA Human Vaccines Market Analysis, by Vaccine Type Market 2023-2030 ($M)
25.1 Conjugate Market 2023-2030 ($M) - Regional Industry Research
25.2 Recombinant Market 2023-2030 ($M) - Regional Industry Research
25.3 Conjugate Vaccines Market 2023-2030 ($M) - Regional Industry Research
25.4 Inactivated Market 2023-2030 ($M) - Regional Industry Research
25.5 Combination Market 2023-2030 ($M) - Regional Industry Research
25.6 Attenuated Market 2023-2030 ($M) - Regional Industry Research
26.MENA Human Vaccines Market Analysis, by Product Market 2023-2030 ($M)
26.1 Pneumococcal Market 2023-2030 ($M) - Regional Industry Research
26.2 Influenza Market 2023-2030 ($M) - Regional Industry Research
26.3 Hepatitis Market 2023-2030 ($M) - Regional Industry Research
26.4 HPV Market 2023-2030 ($M) - Regional Industry Research
26.5 Meningococcal Market 2023-2030 ($M) - Regional Industry Research
26.6 Rotavirus Market 2023-2030 ($M) - Regional Industry Research
26.7 Measles and Rubella Market 2023-2030 ($M) - Regional Industry Research
26.8 Typhoid Market 2023-2030 ($M) - Regional Industry Research
26.9 Combination Market 2023-2030 ($M) - Regional Industry Research
27.MENA Human Vaccines Market Analysis, by Distribution Channel Market 2023-2030 ($M)
27.1 Hospital Pharmacies Market 2023-2030 ($M) - Regional Industry Research
27.2 Drugstores Market 2023-2030 ($M) - Regional Industry Research
28.MENA Human Vaccines Market Analysis, by Age Group Market 2023-2030 ($M)
28.1 Pediatrics Market 2023-2030 ($M) - Regional Industry Research
28.2 Adolescents Market 2023-2030 ($M) - Regional Industry Research
28.3 Adults Market 2023-2030 ($M) - Regional Industry Research
28.4 Geriatrics Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Human Vaccines Market Revenue, 2023-2030 ($M)2.Canada Human Vaccines Market Revenue, 2023-2030 ($M)
3.Mexico Human Vaccines Market Revenue, 2023-2030 ($M)
4.Brazil Human Vaccines Market Revenue, 2023-2030 ($M)
5.Argentina Human Vaccines Market Revenue, 2023-2030 ($M)
6.Peru Human Vaccines Market Revenue, 2023-2030 ($M)
7.Colombia Human Vaccines Market Revenue, 2023-2030 ($M)
8.Chile Human Vaccines Market Revenue, 2023-2030 ($M)
9.Rest of South America Human Vaccines Market Revenue, 2023-2030 ($M)
10.UK Human Vaccines Market Revenue, 2023-2030 ($M)
11.Germany Human Vaccines Market Revenue, 2023-2030 ($M)
12.France Human Vaccines Market Revenue, 2023-2030 ($M)
13.Italy Human Vaccines Market Revenue, 2023-2030 ($M)
14.Spain Human Vaccines Market Revenue, 2023-2030 ($M)
15.Rest of Europe Human Vaccines Market Revenue, 2023-2030 ($M)
16.China Human Vaccines Market Revenue, 2023-2030 ($M)
17.India Human Vaccines Market Revenue, 2023-2030 ($M)
18.Japan Human Vaccines Market Revenue, 2023-2030 ($M)
19.South Korea Human Vaccines Market Revenue, 2023-2030 ($M)
20.South Africa Human Vaccines Market Revenue, 2023-2030 ($M)
21.North America Human Vaccines By Application
22.South America Human Vaccines By Application
23.Europe Human Vaccines By Application
24.APAC Human Vaccines By Application
25.MENA Human Vaccines By Application
26.AstraZeneca, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Bavarian, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Bharat Biotech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.CSL Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Emergent BioSolutions, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.GlaxoSmithKline plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Merck Co., Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Mymetics, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Novartis AG, Sales /Revenue, 2015-2018 ($Mn/$Bn)
36.Pfizer, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
37.Sanofi, Sales /Revenue, 2015-2018 ($Mn/$Bn)
38.Shenzhen Kangtai Biological Products Co., Ltd., Sales /Revenue, 2015-2018 ($Mn/$Bn)
39.Takeda Pharmaceutical Company Limited., Sales /Revenue, 2015-2018 ($Mn/$Bn)